Stack of newspapers on a computer keyboard.

In the News

Greater Wilmington Business Journal (February 2020)

PPD begins trading on Nasdaq

PPD announces the pricing of its initial public offering of 60 million shares of its common stock at $27.00 per share.

wilmington biz logo
WECT (February 2020)

Wilmington pharmaceutical company PPD goes public

Shares of PPD’s common stock begin trading on The Nasdaq Global Select Market under the symbol “PPD.”

WECT6-News-Logo
Regulatory Focus (January 2020)

China’s evolving regulatory environment: Special report

Alistair Davidson, Guoliang Liu and Bill Wang assess how the clinical trial market has responded over the past few years and analyze the future of the China market.

regulatory focus logo
Greater Wilmington Business Journal (January 2020)

PPD files for IPO

PPD announces the launch of its initial public offering of 60 million shares of its common stock.

greater wilmington business journal logo
Triangle Business Journal (January 2020)

PPD eyes China expansion as opportunity grows

PPD is expanding its operations and leadership team in China to provide enhanced clinical development, laboratory, regulatory, site conduct, patient access and post-approval services for international and China-based biopharmaceutical companies.

triangle business journal logo
FierceBiotech (January 2020)

PPD sets out $1B IPO plans as it launches new China labs

The initial public offering price is expected to be between $24.00 and $27.00 per share.

fierce biotech logo
WRAL TechWire (January 2020)

PPD going public – again – with stock offering targeting at least $1.44B

PPD has applied to have its common stock approved for listing on The Nasdaq Global Select Market under the symbol “PPD.”

techwire logo
Clinical Leader (January 2020)

Why site collaboration is key to abating the ‘one and done’ syndrome

There is no question that clinical trial management is becoming more complex. Instead of engaging with patients, an inordinate amount of time is spent learning new systems, completing redundant required training and reentering the same data multiple times.

clinical leader logo
Contract Pharma (January 2020)

Capacity management within functional service partnerships

Tim King and Brian Ford discuss the concept of moving capacity management from sponsors to their FSP vendors.

Contract Pharma